ORLANDO, Fla., Nov. 30 -- SurgiLight Inc. has received a $3 million investment from Global Emerging Markets Inc., an UK-based investment group that specializes in private equity investments.
We are delighted that GEM has concluded the investment which endorses our corporate strategy and provides the platform for further important developments including the expansion of additional international laser centers, R&D and marketing of new products and will assist us as we continue our FDA clinical trials. said J.T. Lin, president and CEO of SurgiLight.